HCPCS J3245

Injection, tildrakizumab, 1 mg (CMS descriptor)

Drugs Drug code Work RVU per service none (2020 fee schedule; adds 0 work RVUs)

28
50th percentile among 6,116 codes billed · 2020
$13M
90th percentile among 6,116 codes billed · 2020
119K
86th percentile among 6,116 codes billed · 2020
4,050
98th percentile among 6,116 codes billed · 2020
7,090
97th percentile among 6,116 codes billed · 2020

Trend

Medicare payment on the code

$0$100M2020: $13M paid20202021: $37M paid20212022: $79M paid20222023: $113M paid20232024: $137M paid2024$137M$0$100M2020: $13M paid20202021: $37M paid20212022: $79M paid20222023: $113M paid20232024: $137M paid2024$137M$0$100M2020: $13M paid20202021: $37M paid20212022: $79M paid20222023: $113M paid20232024: $137M paid2024$137M$0$100M2020: $13M paid20202021: $37M paid20212022: $79M paid20222023: $113M paid20232024: $137M paid2024$137M

Source: CMS Medicare Physician & Other Practitioners public use files (Original Medicare Part B fee-for-service). Data years 2020–2024.

Billers

01002002020: 28 providers20202021: 81 providers20212022: 160 providers20222023: 225 providers20232024: 265 providers202426501002002020: 28 providers20202021: 81 providers20212022: 160 providers20222023: 225 providers20232024: 265 providers202426501002002020: 28 providers20202021: 81 providers20212022: 160 providers20222023: 225 providers20232024: 265 providers202426501002002020: 28 providers20202021: 81 providers20212022: 160 providers20222023: 225 providers20232024: 265 providers2024265

Source: CMS Medicare Physician & Other Practitioners public use files (Original Medicare Part B fee-for-service). Data years 2020–2024.

observed calculated calculated calculated calculated calculated reported
2024265$136,974,230+22%1,278,4094,10011,0200.00
2023225$112,576,292+43%1,028,0163,80010,8200.00
2022160$78,857,640+115%729,7163,8509,7550.00
202181$36,637,315+187%339,7293,8008,2000.00
202028$12,762,527first year in data118,6124,0507,0900.00

Source: CMS Medicare Physician & Other Practitioners public use files (Original Medicare Part B fee-for-service). Data years 2020–2024.

By state

No state has a reportable line for J3245 in 2020.

Top metro areas

No metro area has a reportable line for J3245 in 2020.

Specialties billing J3245 nationally

Dermatology accounts for 60% of payment for J3245 nationally in 2020, across 1 specialties on claims.

observed calculated calculated calculated calculated calculated
Dermatology1554%$7,679,95060%71,3124,754

Not listed: 4 specialties with fewer than 11 billers (small cells).

Source: CMS Medicare Physician & Other Practitioners public use files (Original Medicare Part B fee-for-service). Provider-level lines (fewer than 11 beneficiaries suppressed by CMS); specialty is the provider type on claims. Data year 2020.

Top billers of J3245 nationally

Named top billers are a Pro figure, and Pro is not available to buy, so this list is not shown to any account. The counts and totals by state, metro area and specialty on this page are free.

Original Medicare Part B fee-for-service only; CMS suppresses provider lines with fewer than 11 beneficiaries. How these figures are computed · Limitations